We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.26%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.36B
AUM Growth
+$353M
(+5.9%)
Cap. Flow
+$69.5M
Cap. Flow
% of AUM
1.09%
Top 10 Holdings %
Top 10 Hldgs %
13.3%
Holding
1,175
New
186
Increased
412
Reduced
363
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$25.8M |
| 2 |
Amazon
AMZN
|
+$22.7M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$20.3M |
| 4 |
Everest Group
EG
|
+$18.9M |
| 5 |
LKQ Corp
LKQ
|
+$16.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$36M |
| 2 |
UnitedHealth
UNH
|
+$29.5M |
| 3 |
Merck
MRK
|
+$17.8M |
| 4 |
Baxter International
BAX
|
+$17.5M |
| 5 |
Apple
AAPL
|
+$17.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.46% |
| 2 | Financials | 17.64% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Industrials | 12.01% |
| 5 | Healthcare | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INFI
876
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $322K | 0.01% |
168,727
-45,100
| -21% | -$91.1K |
|
877
Zevra Therapeutics
ZVRA
$563M
| $321K | 0.01% |
3,084
+319
| +12% | +$31.1K |
|
|
TST
878
DELISTED
TheStreet, Inc.
TST
| $320K | 0.01% |
14,682
| – | – |
|
|
TIER
879
DELISTED
TIER REIT, Inc.
TIER
| $319K | 0.01% |
+13,400
| New | +$279K |
|
880
Ezcorp Inc
EZPW
$1.82B
| $308K | ﹤0.01% |
25,600
| – | – |
|
881
Strategic Education
STRA
$1.71B
| $307K | ﹤0.01% |
2,720
| – | – |
|
|
PRGX
882
DELISTED
PRGX Global, Inc.
PRGX
| $307K | ﹤0.01% |
31,685
+16,362
| +107% | +$156K |
|
883
Marchex
MCHX
$79.7M
| $299K | ﹤0.01% |
97,691
+1,400
| +1% | +$3.91K |
|
|
SNR
884
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $299K | ﹤0.01% |
+39,500
| New | +$314K |
|
|
HALL
885
DELISTED
Hallmark Financial Services, Inc.
HALL
| $297K | ﹤0.01% |
2,979
+110
| +4% | +$10.9K |
|
886
Kodak
KODK
$806M
| $296K | ﹤0.01% |
78,019
+17,600
| +29% | +$89.1K |
|
887
Amkor Technology
AMKR
$16.1B
| $295K | ﹤0.01% |
34,400
+5,000
| +17% | +$45.6K |
|
888
Hanmi Financial
HAFC
$943M
| $293K | ﹤0.01% |
+10,330
| New | +$306K |
|
889
Enpro
NPO
$7.05B
| $293K | ﹤0.01% |
+4,192
| New | +$313K |
|
890
Pitney Bowes
PBI
$2.42B
| $292K | ﹤0.01% |
+34,100
| New | +$329K |
|
891
Saic
SAIC
$5.03B
| $291K | ﹤0.01% |
3,600
-36,670
| -91% | -$3.11M |
|
892
ImmunityBio
IBRX
$7.44B
| $288K | ﹤0.01% |
+94,170
| New | +$349K |
|
893
Emergent Biosolutions
EBS
$375M
| $287K | ﹤0.01% |
5,680
-13,000
| -70% | -$677K |
|
894
Syndax Pharmaceuticals
SNDX
$1.84B
| $287K | ﹤0.01% |
+40,815
| New | +$400K |
|
|
CADE
895
DELISTED
Cadence Bank
CADE
| $286K | ﹤0.01% |
8,681
-3,340
| -28% | -$112K |
|
896
Northrim BanCorp
NRIM
$603M
| $282K | ﹤0.01% |
+28,560
| New | +$269K |
|
|
CLR
897
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $282K | ﹤0.01% |
+4,360
| New | +$282K |
|
|
LEAF
898
DELISTED
Leaf Group Ltd.
LEAF
| $282K | ﹤0.01% |
26,015
-11,500
| -31% | -$103K |
|
|
JAX
899
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $281K | ﹤0.01% |
+25,204
| New | +$300K |
|
900
Unum
UNM
$13.8B
| $279K | ﹤0.01% |
+7,530
| New | +$314K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2018 Portfolio in Review
As of Q2 2018, Jacobs Levy Equity Management held 1,175 positions worth $6.36B, up 5.9% from $6.01B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management's Q2 2018 filing shows 186 new, 412 increased, 363 reduced and 161 closed positions. Its largest new stake was LKQ Corp: 486,474 shares worth $15.5M. The largest sale was PepsiCo, an estimated $36M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2018 buy was LKQ Corp: 486,474 shares worth $15.5M.
- Jacobs Levy Equity Management added most to ConocoPhillips in Q2 2018, an estimated $25.8M increase.
- Jacobs Levy Equity Management's biggest Q2 2018 reduction was PepsiCo, cutting an estimated $36M.
- Jacobs Levy Equity Management fully exited General Dynamics in Q2 2018, selling an estimated $11M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $6.36B portfolio in Q2 2018.
- Jacobs Levy Equity Management opened 186 new positions and closed 161 in Q2 2018.
- Jacobs Levy Equity Management's portfolio value rose 5.9% quarter-over-quarter to $6.36B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2018, filed 14 Aug 2018.